Publication Name	World Journal of Gastroenterology
Manuscript ID	5672
Country	Japan

Received	2013-09-20 12:00
Peer-Review Started	2013-09-20 21:28
To Make the First Decision	2013-11-21 20:23
Return for Revision	2013-11-27 18:22
Revised	2013-12-09 15:20
Second Decision	2014-04-16 11:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-16 12:06
Articles in Press	2014-05-23 10:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-07 19:29
Publish the Manuscript Online	2014-07-21 17:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Hepatitis B virus: Where do we stand and what is the next step for eradication?
Manuscript Source	Invited Manuscript
All Author List	Haruki Komatsu
Funding Agency and Grant Number
Corresponding Author	Haruki Komatsu, MD, PhD, Department of Pediatrics, Toho University Sakura Medical Center, 564-1 Shimoshizu Sakura, Chiba 285-8741, Japan. haruki-komatsu@chive.ocn.ne.jp
Key Words	Cancer; Global Alliance for Vaccine and Immunization; Hepatitis B immune globulin; Hepatitis B virus; Hepatocellular carcinoma; Selective vaccination; Universal vaccination; World Health Organization
Core Tip	Hepatitis B (HB) vaccines, which are the first vaccines that have been proven to prevent cancer, have played a crucial role in preventing HB virus (HBV) infection worldwide since their development in the 1980s. In particular, the HB vaccines have been rapidly integrated into the national immunisation programs of low-income countries since the Global Alliance for Vaccine and Immunization was launched in 2000. However, we have still not eradicated HBV. More than 240 million people worldwide are carriers of HBV. The vaccine strategies, current status of HBV infection, and unresolved issues related to controlling HBV infection are discussed in this review.
Publish Date	2014-07-21 17:17
Citation	Komatsu H. Hepatitis B virus: Where do we stand and what is the next step for eradication? World J Gastroenterol 2014; 20(27): 8998-9016
URL	http://www.wjgnet.com/1007-9327/full/v20/i27/8998.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i27.8998

Full Article (PDF)	WJG-20-8998.pdf
Full Article (Word)	WJG-20-8998.doc
Manuscript File	5672-Review.docx
Answering Reviewers	5672-Answering reviewers.pdf
Copyright License Agreement	5672-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5672-Language certificate.pdf
Peer-review Report	5672-Peer review.pdf
Scientific Editor Work List	5672-Scientific editor work list.doc